BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11763111)

  • 1. Side effects of low-dose pyridostigmine bromide are not related to cholinesterase inhibition.
    Cook MR; Gerkovich MM; Sastre A; Graham C
    Aviat Space Environ Med; 2001 Dec; 72(12):1102-6. PubMed ID: 11763111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological and performance effects of pyridostigmine bromide in healthy volunteers: a dose-response study.
    Cook MR; Graham C; Sastre A; Gerkovich MM
    Psychopharmacology (Berl); 2002 Jul; 162(2):186-92. PubMed ID: 12110996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
    Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
    Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular effects of hyoscine in double dose transdermal administration and its reversal by low dose pyridostigmine.
    Alhalel A; Ziv I; Versano D; Ruach M; Alkalay M; Almog S; Izraeli S; Glovinsky J
    Aviat Space Environ Med; 1995 Nov; 66(11):1037-40. PubMed ID: 8588791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seven-day pyridostigmine administration and thermoregulation during rest and exercise in dry heat.
    Wenger B; Quigley MD; Kolka MA
    Aviat Space Environ Med; 1993 Oct; 64(10):905-11. PubMed ID: 8240194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure.
    Behling A; Moraes RS; Rohde LE; Ferlin EL; Nóbrega AC; Ribeiro JP
    Am Heart J; 2003 Sep; 146(3):494-500. PubMed ID: 12947369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological signs and the prevalence of adverse effects of acetylcholinesterase inhibitors in patients with myasthenia gravis.
    Punga AR; Sawada M; Stålberg EV
    Muscle Nerve; 2008 Mar; 37(3):300-7. PubMed ID: 18069667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of symptoms following intake of pyridostigmine during the Persian Gulf war.
    Sharabi Y; Danon YL; Berkenstadt H; Almog S; Mimouni-Bloch A; Zisman A; Dani S; Atsmon J
    Isr J Med Sci; 1991; 27(11-12):656-8. PubMed ID: 1757241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of pyridostigmine on respiratory function in healthy and asthmatic volunteers.
    Ram Z; Molcho M; Danon YL; Almog S; Baniel J; Karni A; Shemer J
    Isr J Med Sci; 1991; 27(11-12):664-8. PubMed ID: 1757243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyridostigmine, diethyltoluamide, permethrin, and stress: a double-blind, randomized, placebo-controlled trial to assess safety.
    Roy MJ; Kraus PL; Seegers CA; Young SY; Kamens DR; Law WA; Cherstniakova SA; Chang DN; Cooper JA; Sato PA; Matulich W; Krantz DS; Cantilena LR; Deuster PA
    Mayo Clin Proc; 2006 Oct; 81(10):1303-10. PubMed ID: 17036555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pyridostigmine bromide on acceleration tolerance and performance.
    Forster EM; Barber JA; Parker FR; Whinnery JE; Burton RR; Boll P
    Aviat Space Environ Med; 1994 Feb; 65(2):110-6. PubMed ID: 8161320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2-4 (SPACE trial).
    Stam M; Wadman RI; Wijngaarde CA; Bartels B; Asselman FL; Otto LAM; Goedee HS; Habets LE; de Groot JF; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL
    BMJ Open; 2018 Jul; 8(7):e019932. PubMed ID: 30061431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyridostigmine in the treatment of orthostatic intolerance.
    Gales BJ; Gales MA
    Ann Pharmacother; 2007 Feb; 41(2):314-8. PubMed ID: 17284509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridostigmine treatment trial in neurogenic orthostatic hypotension.
    Singer W; Sandroni P; Opfer-Gehrking TL; Suarez GA; Klein CM; Hines S; O'Brien PC; Slezak J; Low PA
    Arch Neurol; 2006 Apr; 63(4):513-8. PubMed ID: 16476804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac function during mental stress: cholinergic modulation with pyridostigmine in healthy subjects.
    Sant'anna ID; de Sousa EB; de Moraes AV; Loures DL; Mesquita ET; da Nóbrega AC
    Clin Sci (Lond); 2003 Aug; 105(2):161-5. PubMed ID: 12627998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis.
    De Feo LG; Schottlender J; Martelli NA; Molfino NA
    Muscle Nerve; 2002 Jul; 26(1):31-6. PubMed ID: 12115946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation.
    Bharucha AE; Low P; Camilleri M; Veil E; Burton D; Kudva Y; Shah P; Gehrking T; Zinsmeister AR
    Gut; 2013 May; 62(5):708-15. PubMed ID: 22677718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyridostigmine bromide and the long-term subjective health status of a sample of female reserve component Gulf War veterans: a brief report.
    Schumm WR; Reppert EJ; Jurich AP; Bollman SR; Castelo C; Sanders D; Webb FJ
    Psychol Rep; 2001 Feb; 88(1):306-8. PubMed ID: 11293048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers.
    Blonski W; Vela MF; Freeman J; Sharma N; Castell DO
    J Clin Gastroenterol; 2009 Mar; 43(3):253-60. PubMed ID: 18987553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.